DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo(Institute of Cancer Research), Chris Jones(North Carolina State University), Susan Picton(Helios Klinikum Emil von Behring), Georgia Roumelioti(Institute of Cancer Research), Paula Proszek(BMW (Germany)), Darren Hargrave(Great Ormond Street Hospital), Yura Grabovska(Newcastle University), Jyoti S. Choudhary(Institute of Cancer Research), Amy R. Fairchild(Great Ormond Street Hospital), Sarita Depani(Great Ormond Street Hospital for Children NHS Foundation Trust), Fernando Carceller, Bassel Zebian(King's College London), Juliet C. Gray(University of Southampton), Michael Hubank(Royal Marsden Hospital), Matthew Clarke(Institute of Cancer Research), Valeria Molinari(Institute of Cancer Research), Lisa Howell(Alder Hey Children's NHS Foundation Trust), Jacques Grill(Institut Gustave Roussy), Sara Temelso(Institute of Cancer Research), Giulia Pericoli(Bambino Gesù Children's Hospital), Richard G. Grundy(Brain Tumour Research), Jenny Adamski(Birmingham Women's Hospital), Molina Das(Institute of Cancer Research), Thomas S. Jacques(Great Ormond Street Hospital), Maria Antonietta Ajmone‐Cat(Istituto Superiore di Sanità), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Rebecca F. Rogers(Institute of Cancer Research), Lu Yu(Hubei University of Medicine), Mark Stubbs(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Elisabet Fernandez(Institute of Cancer Research), Simon P. Robinson(Institute of Cancer Research), Patricia O’Hare(Great Ormond Street Hospital), Maria Vinci(Cancer Research UK), Shaun Wilson(Oxford University Hospitals NHS Trust), Jessica K.R. Boult(Institute of Cancer Research)
Cited by 35
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k